Several brokerages have weighed in on AMRN. Amarin Corporation plc was covered by a number of analysts recently, 2 rated the stock as Buy, 0 rated Hold, 0 rated sell and 0 gave an Underperform. Now the shares of Amarin Corporation …
Get free access to your research report on AMRN at: Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and …
Stock
Amarin Corporation plc (NASDAQ:AMRN) announced the publication today of the rationale and design for the …
The RSI oscillates between zero and 100. They buy or sell in enormous chunks. Stock market analysts watching Amarin Corporation PLC (AMRN) have recently changed their ratings on the stock. Whether a stock is in or out of their favor …
These are this Thursday’s top analyst upgrades and downgrades. Alkermes PLC (NASDAQ ... Amarin Corp. PLC …
GNC
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Amarin Corporation plc AMRN, a firm in the Medical - Biomedical and Genetics industry, which could be a great candidate for another beat. …
Amarin Corporation plc (AMRN) will report its next earnings on May 30 BMO ... Amarin Corporation plc and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.07/share. These …
Currently trading close to $6.00, the stock price has gained more than 16% this year. The company has a $1.87 earnings per share (EPS), which is significantly higher than the industry’s average of 18 cents per share. Amarin Corporation …
Lazard Freres & Co. LLC was an advisor to the company. The stock of Amarin Corporation plc (ADR) (NASDAQ:AMRN) fell by 1.44% and closed the previous session at $2.05.